NBCA Survey Shows Gaps in DVT/PE Prophylaxis Among Hospitalized Patients

Data Demonstrate Patient Awareness is Low, Despite Increased Risks

blood clot preventionData from NBCA’s online survey of 500 patients who had been hospitalized for >3 days, show that less than one-third of respondents report DVT prophylaxis with either an anticoagulant pill or anticoagulant injection, even though more than 40% of them report that they had a family member who previously had a blood clot in the leg or lung, and 15% say they had a personal history of a blood clot in the leg or lung.  DVT prophylaxis reported by respondents include:  63% ambulation, 39% compression stockings, 37% mechanical compression, 37% aspirin, 29% anticoagulant injection, and 28% anticoagulant pill. These survey findings are compelling, because they demonstrate the gaps that need to be filled to optimize use of evidence-based DVT/PE prophylaxis, as well as the need to better inform or educate our hospitalized patients about potential risk factors.

Risk Versus Awareness – Read More…
General Public Vs. At-Risk Oncology and Hospitalized Samples  – Read More…
Hospital Findings Quick Facts – Read More…
Survey Methodology – Read More…

1 | 2 | 3 | 4 | 5   Next>>>

The NBCA DVT/PE Awareness Survey was made possible by a grant from Ortho-McNeil™, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Current News

The National Blood Clot Alliance Launches New Council for Emerging Researchers in Thrombosis (CERT)

FOR IMMEDIATE RELEASE: 07/28/2022   The National Blood Clot Alliance (NBCA), the nation’s leading nonprofit patient advocacy organization dedicated to…

The FUVID Study

The FUVID Study (Functional Characterization of Chronic Thromboembolic Venous Disease in Children) is currently open for enrollment to qualified participants.…